Perspectives of the 340B Program
As someone who has a fervent passion for advocacy for the individual and the community as well as increased access to healthcare for all, however, I would argue that “Let 340B” is an unfinished sentence. If I could personally change the statement, I would rather it be stretched to say, “Let 340B the driving force for increased access to healthcare services as it was meant to be.”
What Pharmacy Professionals Need To Know About USP795 & USP797
In an era where the pharmaceutical supply chain is vast and complex, ensuring the safety and integrity of prescription medicines has become a top priority. The Drug Supply Chain Security Act (DSCSA), enacted in November 2013, lays the groundwork for a comprehensive system to track prescription drugs as they journey through the supply chain. Table […]
FDA Approves First Nonprescription Daily Oral Contraceptive: A Game-Change For Pharmacists & Patients
In a landmark decision, the U.S. Food and Drug Administration (FDA) has approved Opill® (norgestrel) tablets for nonprescription use, making it the first daily oral contraceptive available without a prescription in the United States. This approval marks a significant advancement in women’s healthcare and reproductive rights, providing millions of people with increased access to oral […]